Geoff Olson is a Vancouver-based cartoonist.
Copyright, Project CBD. May not be reprinted without permission.
Recommended reading
Scientific studies have established that synthetic, single-molecule CBD has a narrow therapeutic window and requires high doses for efficacy as compared to whole-plant, cannabis-derived CBD.
It’s no secret that many cancer patients are using cannabis to help manage pain, fatigue, nausea, and other side effects of chemotherapy. Preclinical research also shows that plant cannabinoids — like THC and CBD – produce antitumor responses in various animal models of cancer.
Cannabis terpenes interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the medicinal impact of the whole plant is greater than the sum of its parts.
